Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics.
Stuart, RM
Kerr, CC
Haghparast-Bidgoli, H
Estill, J
Grobicki, L
Baranczuk, Z
Prieto, L
Montañez, V
Reporter, I
Gray, RT
Skordis-Worrall, J
Keiser, O
Cheikh, N
Boonto, K
Osornprasop, S
Lavadenz, F
Benedikt, CJ
Martin-Hughes, R
Hussain, SA
Kelly, SL
Kedziora, DJ
Wilson, DP
- Publisher:
- Public Library of Science (PLoS)
- Publication Type:
- Journal Article
- Citation:
- PLoS One, 2017, 12, (10), pp. 1-13
- Issue Date:
- 2017
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Stuart, RM | |
dc.contributor.author | Kerr, CC | |
dc.contributor.author | Haghparast-Bidgoli, H | |
dc.contributor.author | Estill, J | |
dc.contributor.author | Grobicki, L | |
dc.contributor.author | Baranczuk, Z | |
dc.contributor.author | Prieto, L | |
dc.contributor.author | Montañez, V | |
dc.contributor.author | Reporter, I | |
dc.contributor.author | Gray, RT | |
dc.contributor.author | Skordis-Worrall, J | |
dc.contributor.author | Keiser, O | |
dc.contributor.author | Cheikh, N | |
dc.contributor.author | Boonto, K | |
dc.contributor.author | Osornprasop, S | |
dc.contributor.author | Lavadenz, F | |
dc.contributor.author | Benedikt, CJ | |
dc.contributor.author | Martin-Hughes, R | |
dc.contributor.author | Hussain, SA | |
dc.contributor.author | Kelly, SL | |
dc.contributor.author | Kedziora, DJ | |
dc.contributor.author | Wilson, DP | |
dc.date.accessioned | 2022-07-14T05:39:21Z | |
dc.date.available | 2017-09-06 | |
dc.date.available | 2022-07-14T05:39:21Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | PLoS One, 2017, 12, (10), pp. 1-13 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/10453/158911 | |
dc.description.abstract | BACKGROUND: Prioritizing investments across health interventions is complicated by the nonlinear relationship between intervention coverage and epidemiological outcomes. It can be difficult for countries to know which interventions to prioritize for greatest epidemiological impact, particularly when budgets are uncertain. METHODS: We examined four case studies of HIV epidemics in diverse settings, each with different characteristics. These case studies were based on public data available for Belarus, Peru, Togo, and Myanmar. The Optima HIV model and software package was used to estimate the optimal distribution of resources across interventions associated with a range of budget envelopes. We constructed "investment staircases", a useful tool for understanding investment priorities. These were used to estimate the best attainable cost-effectiveness of the response at each investment level. FINDINGS: We find that when budgets are very limited, the optimal HIV response consists of a smaller number of 'core' interventions. As budgets increase, those core interventions should first be scaled up, and then new interventions introduced. We estimate that the cost-effectiveness of HIV programming decreases as investment levels increase, but that the overall cost-effectiveness remains below GDP per capita. SIGNIFICANCE: It is important for HIV programming to respond effectively to the overall level of funding availability. The analytic tools presented here can help to guide program planners understand the most cost-effective HIV responses and plan for an uncertain future. | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | Public Library of Science (PLoS) | |
dc.relation.ispartof | PLoS One | |
dc.relation.isbasedon | 10.1371/journal.pone.0185077 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Copyright: © 2017 Stuart et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.subject.classification | General Science & Technology | |
dc.subject.mesh | Budgets | |
dc.subject.mesh | Cost-Benefit Analysis | |
dc.subject.mesh | Health Priorities | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Budgets | |
dc.subject.mesh | Cost-Benefit Analysis | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | Health Priorities | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Humans | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | Cost-Benefit Analysis | |
dc.subject.mesh | Budgets | |
dc.subject.mesh | Health Priorities | |
dc.title | Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics. | |
dc.type | Journal Article | |
utslib.citation.volume | 12 | |
utslib.location.activity | United States | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | /University of Technology Sydney/Strength - AAI - Advanced Analytics Institute Research Centre | |
utslib.copyright.status | open_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-07-14T05:39:17Z | |
pubs.issue | 10 | |
pubs.publication-status | Published | |
pubs.volume | 12 | |
utslib.citation.issue | 10 |
Abstract:
BACKGROUND: Prioritizing investments across health interventions is complicated by the nonlinear relationship between intervention coverage and epidemiological outcomes. It can be difficult for countries to know which interventions to prioritize for greatest epidemiological impact, particularly when budgets are uncertain. METHODS: We examined four case studies of HIV epidemics in diverse settings, each with different characteristics. These case studies were based on public data available for Belarus, Peru, Togo, and Myanmar. The Optima HIV model and software package was used to estimate the optimal distribution of resources across interventions associated with a range of budget envelopes. We constructed "investment staircases", a useful tool for understanding investment priorities. These were used to estimate the best attainable cost-effectiveness of the response at each investment level. FINDINGS: We find that when budgets are very limited, the optimal HIV response consists of a smaller number of 'core' interventions. As budgets increase, those core interventions should first be scaled up, and then new interventions introduced. We estimate that the cost-effectiveness of HIV programming decreases as investment levels increase, but that the overall cost-effectiveness remains below GDP per capita. SIGNIFICANCE: It is important for HIV programming to respond effectively to the overall level of funding availability. The analytic tools presented here can help to guide program planners understand the most cost-effective HIV responses and plan for an uncertain future.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph